PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Global survey reveals high disconnect between perceptions of obesity among people living with the disease and their doctors

International survey of people living with obesity and their physicians across Europe (including the UK), USA, and Australia examines perceptions about the causes of obesity and treatment goals

2025-05-13
(Press-News.org) A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their perceptions about the causes of obesity and treatment goals. The findings being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), highlight biased misconceptions about obesity which may impact patients’ access to treatment and support.

“Although the causes of weight gain and obesity are diverse and complex—and often beyond an individual’s control—many people still hold biased beliefs that frame obesity as a result of personal choices, such as healthy eating and exercise alone. These misconceptions simplify obesity into a matter of personal willpower, placing full responsibility on the individual and often leading to stigma, rather than encouraging compassionate, evidence-based chronic disease care,” said lead author Dr Ximena Ramos Salas from K&X Ramos AB, a research and consulting agency in Sweden

Although classified as a chronic, relapsing disease, obesity is often not adequately managed or prioritised in healthcare settings. Understanding of the disease among physicians and people with obesity is limited, partly due to deep-rooted weight bias and stigma. As a result, people with obesity lack access to evidence-based and person-centred care.

To understand more about physicians’ and patients’ beliefs about the causes of obesity and therapeutic goals, Dr Ramos Salas and co-authors from Eli Lilly and Company, Adelphi Real World and University of Rome Tor Vergata analysed data from the Adelphi Real World Obesity Disease Specific Programme™—a linked physician and patient cross-sectional survey with retrospective data collection which was conducted in France, Germany, Italy, Spain, the UK, the USA and Australia between October 2023 and April 2024.

Physicians provided data and answered survey questions based on the first eight consultations during the study period with adult patients (aged 18 or older) living with obesity who had a current/prior body mass index (BMI) of 30 kg/m² or higher, or a current/prior BMI of 27 kg/m² or higher, and at least one obesity-related complication. The physician survey included questions on what, in their opinion, were the main reasons for each patient’s obesity and what their treatment goals were for the patient.

Their patients with obesity were then asked to complete a voluntary questionnaire which included questions asking about their perceptions of obesity causes and therapeutic goals. The patient survey included questions on what, in their opinion, were the reasons for their current weight problems and what they were hoping for when they lost weight.

In total, 1,379 responses from patients with obesity and their physicians were analysed by body mass index (BMI) category and the Edmonton Obesity Staging System (EOSS) classification—which classifies obesity on a five-point scale according to severity and underlying health conditions.

Biased misconceptions about obesity
 

The results showed that physicians tended to report behavioural causes for their patients’ obesity—most commonly overeating (69%), followed by lack of exercise (61%), high fat diet (51%), and lack of motivation (49%; see figure 1 in notes to editors).

Notably, physicians were more likely to cite behavioural causes as their patients’ BMI and EOSS category increased. For example, three-quarters of physicians said that the primary cause of obesity in their patients with class III obesity was overeating, while two-thirds cited lack of exercise.
As Dr Ramos Salas explained, “Individuals tend to have more negative attitudes towards people with obesity if they believe that obesity is mostly a behavioural issue.”

Although the majority of people with obesity attributed their obesity to behavioural and socioeconomic causes (87%), they did so to a lesser extent than physicians (98%), reporting much higher levels of biological causes than physicians (81% vs 61%).

People with obesity also regarded genetics as third leading overall cause of their obesity, while physicians ranked genetics as 7th on the list of all causes (see figure in notes to editors).

Differing treatment goals

When asked about treatment goals for their patients with obesity, physicians tended to report health-focused outcomes—most commonly, improving quality of life (around 75%), increasing mobility (roughly 50%), and lowering blood pressure (around 45%), regardless of BMI or EOSS status (see figure 3 in notes top editors).

In contrast, when people with obesity were asked what they were hoping for when they lost weight, they tended to focus on how they would look and feel, regardless of weight loss outcomes. For example, around two-thirds reported hoping to look or feel better, to feel more confident, and be able to fit into smaller clothes sizes, objectives which reflect more psychosocial outcomes, rather than just physical health improvements.

According to Dr Ramos Salas, “Physicians play a key role in shaping treatment decisions and can offer supportive, compassionate care to patients living with obesity by focusing on improvements in overall health and psychosocial well-being, rather than just weight loss. By recognising and addressing internalised weight stigma, doctors can also help patients access additional resources that promote body acceptance, reduce self-blame, and build confidence.”

For interviews with article authors, please contact:

Ximena Ramos Salas, K&X Ramos AB, Sweden E) ximenars@gmail.com T) +46 708 810111

Alternative contact in the ECO Press Room: Tony Kirby T) + 44(0)7834 385827 E) tony@tonykirby.com

Notes to editors:

Please click here for figures 1 and 3

For full abstract click here

Dr Ramos Salas declares no conflicts of interest. Other authors are employees of Eli Lilly, the sponsor of the study.

This press release is based on a poster presentation at the European Congress on Obesity (ECO). All accepted abstracts have been extensively peer reviewed by the congress selection committee. There is no full paper at this stage, but the authors are happy to answer your questions. The research has not yet been submitted to a medical journal for publication. 

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Study reveals distinct mechanisms of action of tirzepatide and semaglutide

2025-05-13
New animal research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals distinct metabolic adjustments to tirzepatide and semaglutide treatment, with tirzepatide temporarily increasing energy expenditure and semaglutide initially reducing energy expenditure. Importantly, the biggest metabolic changes happen directly after treatment and disappear quickly after treatment is stopped. Anti-obesity drugs like tirzepatide and semaglutide have shown substantial promise in promoting weight loss and improving metabolic ...

Mount Sinai Health System to honor Dennis S. Charney, MD, Dean of the Icahn School of Medicine at Mount Sinai, for 18 years of leadership and service at annual Crystal Party  

2025-05-13
New York, NY (May 13, 2025) – Mount Sinai Health System announced today that it will recognize Dennis S. Charney, MD, the outgoing Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai, for 18 years of leadership and service at its 40th annual Crystal Party, Tuesday, May 20, at Pier Sixty, 60 Chelsea Piers. Dr. Charney is one of the longest-serving deans of any medical school nationwide and will step down as Dean on Monday, June 30. He will remain on the faculty at the Icahn School of Medicine at Mount ...

Mapping a new brain network for naming

2025-05-13
How are we able to recall a word we want to say? This basic ability, called word retrieval, is often compromised in patients with brain damage. Interestingly, many patients who can name words they see, like identifying a pet in the room as a “cat”, struggle with retrieving words in everyday discourse. Scientists have long sought to understand how the brain retrieves words during speech. A new study by researchers at New York University sheds light on this mystery, revealing a left-lateralized network in the dorsolateral prefrontal cortex that plays a crucial role in naming. The findings, published in Cell Reports, provide new insights into ...

Healthcare company Watkins-Conti announces publication of positive clinical trial results for FDA-cleared Yōni.Fit bladder support

2025-05-13
EDMOND, Okla. – May 13, 2025 -- Watkins-Conti Products, Inc. ("Watkins-Conti"), a company that develops innovative solutions for women's pelvic health, today announced the peer-reviewed publication of clinical trial results evaluating Yōni.Fit® Bladder Support ("Yōni.Fit®"). Designed and manufactured in the United States, Yōni.Fit® obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) in 2024 for the temporary management of urine ...

Prominent chatbots routinely exaggerate science findings, study shows

2025-05-13
When summarizing scientific studies, large language models (LLMs) like ChatGPT and DeepSeek produce inaccurate conclusions in up to 73% of cases, according to a new study by Uwe Peters (Utrecht University) and Benjamin Chin-Yee (Western University, Canada/University of Cambridge, UK). The researchers tested the most prominent LLMs and analyzed thousands of chatbot-generated science summaries, revealing that most models consistently produced broader conclusions than those in the summarized texts. Surprisingly, prompts ...

First-ever long read datasets added to two Kids First studies

2025-05-13
This new Kids First data creates a fuller understanding of how genetics contributes to childhood cancers and congenital disorders, opening additional doors for prevention and treatment.  WHO: The Gabriella Miller Kids First Pediatric Research Program (Kids First), an initiative of the National Institutes of Health (NIH). Kids First data, tools, and resources are available via the Kids First Data Resource Center (DRC). WHAT: The 2025 releases represent the first batch of long read sequencing data ...

Dual-laser technique lowers Brillouin sensing frequency to 200 MHz

2025-05-13
Scientists have developed a dual-laser Brillouin optical correlation-domain reflectometry (BOCDR) system that uses two frequency-modulated lasers. By scanning the relative modulation phase between the pump and reference lasers, the setup measures strain and temperature all along an optical fiber. In a proof-of-concept test on a 13-meter silica fiber, the team recorded Brillouin gain spectra (BGS) at only about 200 MHz—over 50 times lower than the usual 11 GHz band. Their research was published in Journal of Physics: Photonics on April 25, 2025. “The dual-laser approach makes BOCDR equipment simpler, more cost-effective, ...

Zhaoqi Yan named a 2025 Warren Alpert Distinguished Scholar

2025-05-13
SAN FRANCISCO—Zhaoqi Yan, PhD, a scientist at Gladstone Institutes, has been named a 2025 Warren Alpert Distinguished Scholar. The fellowship award is given annually to five postdoctoral researchers in the United States who demonstrate exceptional creativity in the field of neuroscience. Yan studies how blood proteins that leak into the brain through damaged blood vessels can drive brain inflammation and neurodegeneration. Molecular mechanisms behind this dysfunction in the blood-brain barrier remain unclear, and effective therapeutic strategies are lacking—something Yan hopes to change. With the support from the Warren Alpert Foundation, he will use cutting-edge techniques to ...

Editorial for the special issue on subwavelength optics

2025-05-13
The field of subwavelength optics has opened new avenues for investigating light–matter interactions by enabling the exploration of novel phenomena at the subwavelength scale. In recent decades, advancements in fundamental understanding and micro–nano-technologies have significantly propelled the development of subwavelength optics and its practical applications. For instance, progress in surface plasmon subwavelength optics, which facilitates the confinement of light at scales below the diffraction limit, forms a basis for transformative applications such as sub-diffraction-limit imaging, waveguiding and sensing. Moreover, advancements ...

Oyster fossils shatter myth of weak seasonality in greenhouse climate

2025-05-13
An international research team studying fossilized oyster shells has revealed substantial annual temperature variation in sea water during the Early Cretaceous. The finding overturns the assumption that Earth's greenhouse periods are marked by universally warmer and uniformly stable temperatures.   The team, led by Prof. DING Lin from the Institute of Tibetan Plateau Research at the Chinese Academy of Sciences (CAS), in collaboration with researchers from the Senckenberg Biodiversity and Climate ...

LAST 30 PRESS RELEASES:

Eye for trouble: Automated counting for chromosome issues under the microscope

The vast majority of US rivers lack any protections from human activities, new research finds

Ultrasound-responsive in situ antigen "nanocatchers" open a new paradigm for personalized tumor immunotherapy

Environmental “superbugs” in our rivers and soils: new one health review warns of growing antimicrobial resistance crisis

Triple threat in greenhouse farming: how heavy metals, microplastics, and antibiotic resistance genes unite to challenge sustainable food production

Earthworms turn manure into a powerful tool against antibiotic resistance

AI turns water into an early warning network for hidden biological pollutants

Hidden hotspots on “green” plastics: biodegradable and conventional plastics shape very different antibiotic resistance risks in river microbiomes

Engineered biochar enzyme system clears toxic phenolic acids and restores pepper seed germination in continuous cropping soils

Retail therapy fail? Online shopping linked to stress, says study

How well-meaning allies can increase stress for marginalized people

Commercially viable biomanufacturing: designer yeast turns sugar into lucrative chemical 3-HP

Control valve discovered in gut’s plumbing system

George Mason University leads phase 2 clinical trial for pill to help maintain weight loss after GLP-1s

Hop to it: research from Shedd Aquarium tracks conch movement to set new conservation guidance

Weight loss drugs and bariatric surgery improve the body’s fat ‘balance:’ study

The Age of Fishes began with mass death

TB harnesses part of immune defense system to cause infection

Important new source of oxidation in the atmosphere found

A tug-of-war explains a decades-old question about how bacteria swim

Strengthened immune defense against cancer

Engineering the development of the pancreas

The Journal of Nuclear Medicine ahead-of-print tip sheet: Jan. 9, 2026

Mount Sinai researchers help create largest immune cell atlas of bone marrow in multiple myeloma patients

Why it is so hard to get started on an unpleasant task: Scientists identify a “motivation brake”

Body composition changes after bariatric surgery or treatment with GLP-1 receptor agonists

Targeted regulation of abortion providers laws and pregnancies conceived through fertility treatment

Press registration is now open for the 2026 ACMG Annual Clinical Genetics Meeting

Understanding sex-based differences and the role of bone morphogenetic protein signaling in Alzheimer’s disease

Breakthrough in thin-film electrolytes pushes solid oxide fuel cells forward

[Press-News.org] Global survey reveals high disconnect between perceptions of obesity among people living with the disease and their doctors
International survey of people living with obesity and their physicians across Europe (including the UK), USA, and Australia examines perceptions about the causes of obesity and treatment goals